Osteosynthesis in Vancouver type B1 periprosthetic fractures.

INTRODUCTION: The incidence of hip periprosthetic fractures (PPF) has been increasing in recent years. In Vancouver type B1 there are several osteosynthesis options. The aim of this paper is to assess both the treatment and results of Vancouver type B1 PPF in patients operated at our centre. MATERIAL AND METHOD: An observational retrospective study of patients operated at Hospital Universitario Miguel Servet for type B1 PPF via osteosynthesis with plate between January 2014 and March 2017. Such details were documented and analysed as type of implant used for fixation, patient demographics, complications, time to union and function score using the Harris Hip Score. The minimum follow up was 2 years. RESULTS: Overall, 37 patients (21 women)  were available for review with a mean age of 80.7 years (range 54-99). 8 of these patients died, with an average age of 85.6 (83-95). Out of these 8 dead patients, 4 died in the first year, with an average age of 87 (83-95). 19 fractures had cemented stems whereas 18 were uncemented. According to prosthesis type, 8 had a cemented partial arthroplasty, 11 a cemented total hip arthroplasty (THA), 18 a non-cemented THA; with an average period until PPF of 2.5 years (0.2-5.6), 7 years (0.09-18.1) and 8.1 years (2.6-12.7) respectively. Devises used for stabilisation of the fracture included 27 Cable-Ready® plates (Zimmer-Biomet), 5 Dall-Miles® plates (Stryker) and 5 femur NCB® plates (Zimmer-Biomet). Complications included 5 acute superficial infections of surgical wound, 1 chronic infection, 5 pressure ulcers (4 sacral, 1 heel), 7 patients required intra-operational blood transfusion. The mean time to union was 10.35 weeks (range 6-13). The mean Harris Hip Score postoperatively was 65 (44-95). DISCUSSION: Treatment via open reduction and internal fixation with locked lateral plate covering most of the femur in elderly patients or those with poor bone quality, or a plate with proximal cerclages and distal screws in patients with better bone quality are appropriate treatment methods. To achieve good results using these techniques, we consider minimisation of soft tissue dissection highly important likewise using a meticulous osteosynthesis technique with special attention to biology and biomechanics.

On the relevance of preoperative haemoglobin optimisation within a Patient Blood Management programme for elective hip arthroplasty surgery.

BACKGROUND: Preoperative anaemia is highly prevalent among patients scheduled for total hip arthroplasty (THA), and is the main risk factor for perioperative red blood cell transfusion (RBCT). This retrospective cohort study aimed at assessing whether preoperative haemoglobin (Hb) optimisation reduced RBCT rates and improved outcome in this patient population. MATERIALS AND METHODS: All patients entered a Patient Blood Management (PBM) programme consisting of in-hospital erythropoiesis stimulation, tranexamic acid administration, and a restrictive RBCT policy. Data from preoperatively anaemic patients (Hb <13 g/dL) who underwent THA, before (2015-2016, control group, n=75) or after (2017-2018, study group, n=70) the incorporation of a preoperative Hb optimisation protocol (Ferric carboxymaltose IV, 1,000 mg ± epoetin-α, 40,000 IU; administered 4 weeks prior to surgery) to the PBM programme underwent a comparative analysis. RESULTS: Haemoglobin concentrations at preoperative assessment were similar (12.1±0.7 g/dL vs 12.2±0.7 g/dL, for study and control groups, respectively; p=0.129). At hospital admission, significantly higher Hb were observed in the study group (13.4±0.8 g/dL vs 12.2±0.7 g/dL, respectively; p=0.001), with anaemia being corrected in 79% of cases. Compared to the control group, reduced perioperative RBCT rate (4% vs 24%, respectively; p=0.001), shorter length of hospital stay (6 [range 5-7] days vs 7 [5-8 days], respectively; p=0.002), and increased proportion of patients being discharged directly to their home (74% vs 47%, respectively; p=0.01) were observed in the study group. No treatment-related side-effects were witnessed. DISCUSSION: Within a PBM programme for THA, preoperative Hb optimisation was efficacious at correcting anaemia and minimising RBCT requirements, thus contributing to an improvement in postoperative outcomes.

[Transfusion trend in total hip arthroplasty following the implementation of a Patient Blood Management protocol.] / Tendencia transfusional en la artroplastia total de cadera tras la implantación de un protocolo de "Patient Blood Management".

Introduction: Total hip arthroplasty is a successful and safe surgical procedure, but it involves an associated blood loss. When this surgery is carried out on a scheduled basis, the implantation of a multimodal approach of Patient Blood Management (PBM) will significantly reduce transfusion needs. Objective: To present the clinical-analytical results and the transfusion incidence after the implantation of a PBM protocol in those patients who are going to undergo prosthetic hip surgery. Materials and methods: Restrospective, unicentric, observational and analytical study, among those patients undergoing primary elective hip arthroplasty between January 2017 and February 2019. In all of them, a PBM protocol has been applied, focused on the development of an optimization program of preoperative anemia, the use of topical tranexamic acid and the adoption of a restrictive transfusion policy. Results: The study included a total of 384 patients, where only 9 required allogeneic blood transfusion (transfusion rate: 2.34%). In the analysis of transfused patients, they were found to have a longer hospital stay (8 ± 2.9 Vs 5.3 ± 2.9 days; p = 0.007) and a higher rate of complications (22.2% vs. 3, 9%; p = 0.017), with respect to those who avoided the TSA. Conclusion: The application of an adequate multimodal protocol of PBM, brings us closer to the utopia of bloodless surgery in prosthetic surgery, resulting in a cost-effective model that significantly reduces the TSA in primary hip arthroplasty.

Introducción: La artroplastia total de cadera es un procedimiento quirúrgico exitoso y seguro, pero que conlleva una inherente perdida sanguínea asociada. Cuando esta cirugía se lleva a cabo de forma programada, la implantación de un abordaje multimodal de Patient Blood Management (PBM), permitirá reducir significativamente las necesidades transfusionales. Objetivo: Presentar los resultados clínico-analíticos y la incidencia transfusional tras la implantación de un protocolo de PBM en aquellos pacientes que van a someterse a una cirugía protésica de cadera. Materiales y métodos: Estudio restrospectivo, unicentrico, observacional y analítico, entre aquellos pacientes sometidos a una artroplastia primaria de cadera electiva entre enero de 2017 y Febrero de 2019. En todos ellos, se ha aplicado un protocolo de PBM, centrado en el desarrollo de un programa de optimización de la anemia preoperatoria, la utilización de ácido tranexámico tópico y la adopción de una política transfusional restrictiva. Resultados: El estudio incluyó un total de 384 pacientes, donde únicamente 9 precisaron transfusión de sangre alogénica (Tasa transfusional: 2,34%). En el análisis de los pacientes transfundidos, se encontró que presentaban una mayor estancia hospitalaria (8 ±2,9 Vs 5,3 ±2,9 días; p=0,007) y un mayor índice de complicaciones (22,2% vs 3,9%; p=0,017), respecto a aquellos que eludieron la TSA. Conclusión: La aplicación de un adecuado protocolo multimodal de PBM, nos acerca a la utopía de una cirugía sin sangre en la cirugía protésica, resultando un modelo costo-efectivo que permite reducir de forma significativa la TSA en la artroplastia primaria de cadera.

Adaptive Bone Remodeling With New Design of the ABG Stem. Densitometric Study.

To establish the pattern of bone remodeling caused by a cementless, anatomic implant, we intend to evaluate the changes in bone mineral density observed after surgery in the Gruen zones. A controlled, prospective study was carried out, in which a group of 37 patients with primary coxarthrosis were densitrometrically analyzed over the 1 year period following the implant of an ANATO stem (Stryker). The patient's healthy hip was taken as the control. Any differences in the remodeling pattern were compared according to age, body mass index, and implant size. Decreases in bone mineral density were observed after 3 months in all of the zones studied. However, this bone mineral density loss was recovered in all zones by the end of the study, except in zone 7 where a decrease of 7.2% in bone mass was observed. In zones 2 and 6, where more loads are transmitted, bone mass preservation, in accordance with Wolff's law, can be seen. No differences were found in the remodeling pattern in relation to age and body mass index. There were also no differences related to stem size except in zones 1 and 7. The ANATO stem achieves an efficient transmission of loads between the stem and the proximal femur, providing enough mechanical loads for bone preservation. It is only in zone 7 where significant bone atrophy can be observed, attributable to the damage that this area suffers during the surgical process and the subsequent stress-shielding caused by the implant design.

SNPs in bone-related miRNAs are associated with the osteoporotic phenotype.

Biogenesis and function of microRNAs can be influenced by genetic variants in the pri-miRNA sequences leading to phenotypic variability. This study aims to identify single nucleotide polymorphisms (SNPs) affecting the expression levels of bone-related mature microRNAs and thus, triggering an osteoporotic phenotype. An association analysis of SNPs located in pri-miRNA sequences with bone mineral density (BMD) was performed in the OSTEOMED2 cohort (n = 2183). Functional studies were performed for assessing the role of BMD-associated miRNAs in bone cells. Two SNPs, rs6430498 in the miR-3679 and rs12512664 in the miR-4274, were significantly associated with femoral neck BMD. Further, we measured these BMD-associated microRNAs in trabecular bone from osteoporotic hip fractures comparing to non-osteoporotic bone by qPCR. Both microRNAs were found overexpressed in fractured bone. Increased matrix mineralization was observed after miR-3679-3p inhibition in human osteoblastic cells. Finally, genotypes of rs6430498 and rs12512664 were correlated with expression levels of miR-3679 and miR-4274, respectively, in osteoblasts. In both cases, the allele that generated higher microRNA expression levels was associated with lower BMD values. In conclusion, two osteoblast-expressed microRNAs, miR-3679 and miR-4274, were associated with BMD; their overexpression could contribute to the osteoporotic phenotype. These findings open new areas for the study of bone disorders.

Estudio densitométrico de diez años de remodelación femoral tras la implantación de un vástago anatómico / Étude densitométrique de dix ans d'un remodelage fémoral après implantation d'une tige anatomique / A Ten-Year sensitometric study of femoral remodeling after implantation of an anatomical stem

Introducción: la absorciometría dual con rayos X es comúnmente utilizada para cuantificar la remodelación ósea periprotésico, normalmente en seguimientos a corto plazo. Objetivo: determinar los patrones de remodelado producidos por vástago anatómico, mediante la cuantificación de cambios en la densidad mineral ósea en las 7 zonas de Gruen, durante el seguimiento, así como analizar la influencia de otros factores en el remodelado óseo. Métodos: se realizó un estudio prospectivo (10 años de seguimiento) a un grupo de 39 pacientes a los que se implantó una prótesis total de cadera no cementada. Se utilizó la cadera sana contralateral como control. Para cuantificar la remodelación femoral periprotésica se utilizó la absorciometría dual con rayos X en las 7 zonas de Gruen. Las mediciones de masa ósea se realizaron a los 15 días, 1, 3 y 10 años tras la intervención en la cadera no operada y a los 15 días, 1, 3, 5 y 10 años de la operación en la cadera protetizada. Se analizó también la influencia de otros factores en el remodelado óseo (sexo, índice de masa corporal y masa ósea preoperatoria). Resultados: se halló un descenso de la densidad mineral ósea del 7 por ciento en la zona 1 de Gruen y del 24,1 por ciento en la zona 7 de Gruen al final del décimo año. El sexo, el índice de masa corporal y la masa ósea preoperatoria no fueron estadísticamente relevantes en su influencia sobre el remodelado óseo. Conclusión: la remodelación ósea periprotésica depende en su mayor parte del implante, no se halló correlación con sexo, índice de masa corporal o masa ósea preoperatoria(AU)

Introduction: Dual X-ray absorptiometry is commonly used to quantify periprosthetic bone remodeling, usually for short-term follow up. Objective: determine patterns of remodeling caused by anatomical stem, by quantifying changes in bone mineral density in the 7 Gruen zones during follow up and analyze the influence of other factors in bone remodeling. Methods: a prospective study (10 year follow-up) was performed to a group of 39 patients undergoing uncemented total hip prosthesis. The healthy hip was used as control. Dual X-ray absorptiometry in Gruen zones 7 was used to quantify the femoral periprosthetic remodeling. Bone mass measurements were performed at 15 days, 1, 3 and 10 years after surgery on the non-operated hip, and at 15 days, 1, 3, 5 and 10 years of operation in the prosthetic hip. The influence of other factors in bone remodeling (sex, body mass index, and preoperative bone mass) was also analyzed. Results: 7 percent of decrease in bone mineral density was found in Gruen zone 1 and 24.1 percent was found in Gruen zone 7 at the end of the tenth year of follow up. Sex, body mass index and preoperative bone density were not statistically significant in its influence on bone remodeling. Conclusions: periprosthetic bone remodeling depends mainly on the implant. No correlation has been found with sex, body mass index and preoperative preoperative bone density(AU)

Introduction: l'absorptiométrie biphotonique à rayons X est fréquemment utilisée pour évaluer le remodelage osseux péri-prothétique, notamment par des suivis à court terme. Objectif: le but de cette étude est de déterminer les standards du remodelage osseux péri-prothétique produits par une tige anatomique, et d'analyser également l'influence d'autres facteurs sur le remodelage osseux. Méthodes: une étude prospective (suivi de 10 ans) d'un groupe de 39 patients, ayant subi une implantation de prothèse de hanche sans ciment, a été réalisée. Afin d'évaluer le remodelage fémoral périprothétique, on a effectué une absorptiométrie biphotonique à rayons X dans les 7 zones de Gruen. On a mesuré la DMO de la hanche non-opérée aux 15 jours et 1, 3, et 10 ans après la chirurgie, ainsi que la DMO de la hanche opérée aux 15 jours et 1, 3, 5, et 10 ans après la chirurgie. On a également analysé le retentissement d'autres facteurs (sexe, indice de masse corporelle, densité osseuse préopératoire) sur le remodelage osseux. Résultats: à la fin de la dixième année, on a trouvé une perte de la DMO de 7 pourcent dans la zone 1, et de 24.1 pourcent dans la zone 7. Le sexe, l'indice de masse corporelle et la masse osseuse préopératoire n'ont pas statistiquement influé sur le remodelage osseux. Conclusions: le remodelage osseux péri-prothétique dépend notamment de l'implant ; on n'a pas trouvé de corrélation avec le sexe, l'indice de masse corporelle ou la densité osseuse préopératoire(AU)